Interventional Cardiology Devices Market Is Expected to Progress at a CAGR of 2.9% Due to Increasing CAD Cases
Boston Scientific, Abbott Vascular, and Medtronic were the leading providers of interventional cardiology devices in 2014, collectively racking up a share in the market of 66.9% in value. Outside of this majority share, the remainder competitive landscape is spread out across the globe in small and medium sized players.
View full press release